Parkinson's disease (PD) is the second most common neurodegenerative disease, with patient numbers being expected to double worldwide in the next 20 years. The detailed molecular and cellular mechanisms underlying its pathogenesis ...
Nov 12, 2020
0
16
Parkinson's disease is a neurodegenerative disorder that leads to significant disturbances to motor control resulting in involuntary tremor, shuffling gait, muscular rigidity, and other problems. The disease also leads to ...
Nov 12, 2020
0
19
A device that mimics the brain cells affected by Parkinson's disease could help find new treatments for the condition. The device is described in the Elsevier journal Organs-on-a-Chip. "We have created human neurons that ...
Nov 10, 2020
0
3
The effect of dopaminergic medication on the learning abilities of patients with Parkinson's disease turns out to be linked to the presence of tremor symptoms. In patients who do not experience tremor, dopaminergic medication ...
Nov 6, 2020
0
39
Johns Hopkins Medicine researchers have mapped out the cellular pathway that connects the most common genetic mutation associated with Parkinson's disease to brain cell death. In a new study, they show that the mutation initiates ...
Oct 27, 2020
0
7
Can COVID-19 infection increase the risk of developing Parkinson's disease?
Oct 22, 2020
0
8
New research shows a simple skin test can accurately identify Parkinson's disease, demonstrating for the first time the feasibility of the method. Currently diagnosed by clinical signs and symptoms but only definitively diagnosed ...
Oct 21, 2020
0
7
A gut hormone, ghrelin, is a key regulator of new nerve cells in the adult brain, a Swansea-led research team has discovered. It could help pave the way for new drugs to treat dementia in patients with Parkinson's Disease.
Oct 21, 2020
0
20
Bacteria in the small intestine can deaminate levodopa, the main drug that is used to treat Parkinson's disease. Bacterial processing of the unabsorbed fractions of the drug results in a metabolite that reduces gut motility. ...
Oct 19, 2020
0
124
A new study of approximately 80,000 patients shows that people with Parkinson's disease (PD) have a 30% higher risk of dying from COVID-19 than people without the neurodegenerative condition.
Oct 1, 2020
0
1
